Skip To The Main Content
Important Announcement

Regulatory Response and Emerging Policies on COVID-19

To contact the commenting team, a user must be logged into their PDA account. Only full PDA memberships are able to interact with the commenting team.
FDA: Development and Licensure of Vaccines to Prevent COVID-19
Comments were provided to offer suggestions that may provide clarity for agency staff and regulated industry, as well as accelerate bringing the products to market.
Publication Date: Jun 1, 2020
FDA: Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
Comments were provided to the FDA to share recent industry experience with the subject matter.
Publication Date: Mar 1, 2011